Wechter; William J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wechter; William J..The latest application filed is for "use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease".

Company Profile

0.18.12

Wechter; William J. - Ojai CA
Wechter; William J. - Redlands CA
Wechter; William J. - Kalamazoo MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20070037878 - Wechter; William J.	2007-02-15
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20070037879 - Wechter; William J.	2007-02-15
Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20060223881 - Wechter; William J.	2006-10-05
R-NSAID esters and their use Grant 7,074,826 - Wechter , et al. July 11, 2	2006-07-11
Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease Grant 6,908,943 - Wechter June 21, 2	2005-06-21
Therapeutically active compounds App 20040152777 - Wechter, William J. ; et al.	2004-08-05
Methods for screening compounds for use in the treatment of disease App 20040152146 - Wechter, William J. ; et al.	2004-08-05
Fat substitutes App 20040151758 - Wechter, William J. ; et al.	2004-08-05
R-NSAID esters and their use App 20040067914 - Wechter, William J. ; et al.	2004-04-08
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20040058986 - Wechter, William J.	2004-03-25
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20040058987 - Wechter, William J.	2004-03-25
Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease Grant 6,555,575 - Wechter April 29, 2	2003-04-29
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20020165268 - Wechter, William J.	2002-11-07
Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease Grant 6,410,589 - Wechter June 25, 2	2002-06-25
Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease App 20010031782 - Wechter, William J.	2001-10-18
Pharmaceutical composition and method for treatment of inflammation App 20010012849 - Wechter, William J.	2001-08-09
Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease Grant 6,242,479 - Wechter June 5, 2	2001-06-05
Prophylactic composition and method for alzheimer's Disease Grant 6,160,018 - Wechter , et al. December 12, 2	2000-12-12
Natriuretic compounds Grant 6,150,402 - Wechter , et al. November 21, 2	2000-11-21
Natriuretic compounds Grant 6,083,982 - Wechter , et al. July 4, 2	2000-07-04
Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of natriuretic disease Grant 6,048,891 - Wechter April 11, 2	2000-04-11
Method and composition for treating cystic fibrosis Grant 5,981,592 - Wechter , et al. November 9, 1	1999-11-09
Colorectal chemoprotective composition and method of preventing colorectal cancer Grant 5,955,504 - Wechter , et al. September 21, 1	1999-09-21
Natriuretic hormone Grant 5,422,393 - Bricker , et al. * June 6, 1	1995-06-06
Antipyretic and analgesic methods using optically pure R-ketorolac Grant 5,382,591 - Barberich , et al. January 17, 1	1995-01-17
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen Grant 5,331,000 - Young , et al. July 19, 1	1994-07-19
Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease Grant 5,190,981 - Wechter March 2, 1	1993-03-02
Cytidine nucleoside compound Grant 4,096,324 - Kelly , et al. June 20, 1	1978-06-20
Arabinofuranosyl N.sup.4 -aminoacyl cytosine containing compounds Grant 3,975,367 - Gish , et al. August 17, 1	1976-08-17
Ara-cytidine derivatives and process of preparation Grant 3,894,000 - Wechter , et al. July 8, 1	1975-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.